"It's a guided missile. It's able to bring the chemotherapy directly to the cancer cell," said the study leader, Dr. Ian Krop of the Dana-Farber Cancer Institute in Boston. Results were disclosed at ...

Currently, there is no standard treatment for these patients,” says Ian Krop, an oncologist at the Dana–Farber Cancer Institute in Boston, USA, and lead investigator of the TDM4374g trial.